Steroid-sparing effect of ciclosporin A 1 mg/mL: 5-year case series of 107 children and young people with vernal keratoconjunctivitis
Background/aims To explore the steroid-sparing and other therapeutic effects of ciclosporin A (CsA) 1 mg/mL in the management of vernal keratoconjunctivitis (VKC).Methods Open retrospective single-group interventional consecutive cohort study (case series) of 107 children and young people (CYP) age...
Main Authors: | Melanie Hingorani, Clare Roberts, Virginia Calder, Annegret Hella Dahlmann-Noor, Kirithika Muthusamy |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-12-01
|
Series: | BMJ Open Ophthalmology |
Online Access: | https://bmjophth.bmj.com/content/7/1/e001040.full |
Similar Items
-
Clinical Outcomes of Topical 0.1% Ciclosporin Cationic Emulsion Used on Label in Children with Vernal Keratoconjunctivitis
by: Giuseppe Giannaccare, et al.
Published: (2023-04-01) -
Efficacy, Safety and Steroid-sparing Effect of Topical Cyclosporine A 0.05% for Vernal Keratoconjunctivitis in Indian Children
by: Arkendu Chatterjee, et al.
Published: (2019-10-01) -
Acute hydrops in keratoglobus with vernal keratoconjunctivitis
by: Gupta V, et al.
Published: (1985-01-01) -
Evaluation of Health-Related Quality of Life In Children With Vernal Keratoconjunctivitis Using Quality Of Life In Children With Vernal Keratoconjunctivitis Questionnaire
by: Khusus, Khairil Ridzwan Kamalul
Published: (2021) -
Immunopharmacology in Vernal Keratoconjunctivitis: Current and Future Perspectives
by: DeGaulle I. Chigbu, et al.
Published: (2021-07-01)